Characterization of [3H]mazindol binding sites in cultured monkey amniotic epithelial cells.
- 1 January 2000
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 279 (1) , 37-40
- https://doi.org/10.1016/s0304-3940(99)00938-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Detection of dopamine D2 receptor mRNA and binding sites in monkey amniotic epithelial cellsJournal of Neuroscience Research, 1999
- Evidence for the presence of dopamine D1 receptor mRNA and binding sites in monkey amniotic epithelial cellsNeuroscience Letters, 1999
- Synthesis and release of catecholamines by cultured monkey amniotic epithelial cellsJournal of Neuroscience Research, 1998
- Synthesis of dopamine from l-3,4-dihydroxyphenylalanine by human amniotic epithelial cellsEuropean Journal of Pharmacology, 1998
- Evidence for synthesis and release of catecholamines by human amniotic epithelial cellsNeuroReport, 1997
- Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium.Proceedings of the National Academy of Sciences, 1994
- Modulation of [3H]mazindol binding sites in rat striatum by dopaminergic agentsEuropean Journal of Pharmacology, 1993
- Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeysBrain Research, 1992
- Studies in postmortem dopamine uptakeJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1987
- Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranesBiochemical Pharmacology, 1985